Stock analysts at Evercore ISI began coverage on shares of Tyme Technologies (NASDAQ:TYME) in a research report issued to clients and investors on Friday, November 17th. The firm set an “outperform” rating and a $7.00 price target on the stock. Evercore ISI’s price objective suggests a potential upside of 85.19% from the stock’s current price.
Tyme Technologies (NASDAQ TYME) traded down $0.12 during mid-day trading on Friday, hitting $3.78. The stock had a trading volume of 103,783 shares, compared to its average volume of 43,623. Tyme Technologies has a one year low of $1.01 and a one year high of $9.50.
In related news, COO Michael Demurjian sold 50,000 shares of the company’s stock in a transaction on Tuesday, November 14th. The shares were sold at an average price of $3.34, for a total value of $167,000.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.
TRADEMARK VIOLATION NOTICE: “Tyme Technologies (NASDAQ:TYME) Now Covered by Analysts at Evercore ISI” was first posted by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are reading this piece on another domain, it was copied illegally and reposted in violation of U.S. and international trademark & copyright law. The original version of this piece can be read at https://www.dispatchtribunal.com/2017/12/04/tyme-technologies-inc-tyme-now-covered-by-evercore-isi.html.
About Tyme Technologies
Tyme Technologies, Inc is a clinical-stage biotechnology company. The Company is focused on developing cancer therapeutics that is intended to be broadly effective across tumor types and have low toxicity profiles. The Company’s therapeutic approach is designed to take advantage of a cancer cell’s innate metabolic weaknesses to compromise its defenses, leading to cell death through oxidative stress and exposure to the body’s natural immune system.
Receive News & Ratings for Tyme Technologies Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tyme Technologies Inc. and related companies with MarketBeat.com's FREE daily email newsletter.